Press "Enter" to skip to content

New patent expiration for Glaxosmithkline drug ARNUITY ELLIPTA

0
Copyright © DrugPatentWatch. Originally published at New patent expiration for Glaxosmithkline drug ARNUITY ELLIPTA

Annual Drug Patent Expirations for ARNUITY+ELLIPTA
Annual Drug Patent Expirations for ARNUITY+ELLIPTA

Arnuity Ellipta is a drug marketed by Glaxosmithkline and is included in one NDA. It is available from one supplier. There are eight patents protecting this drug.

ARNUITY ELLIPTA drug price trends.

Drug patent litigation for ARNUITY ELLIPTA.

This drug has two hundred and fifty-eight patent family members in forty-one countries.

The generic ingredient in ARNUITY ELLIPTA is fluticasone furoate. One supplier is listed for this compound. Additional details are available on the fluticasone furoate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent expiration for Glaxosmithkline drug ARNUITY ELLIPTA
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

DrugPatentWatch - Make Better Decisions